Literature DB >> 33320017

Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?

Shelly Pathania1, Pankaj Kumar Singh2.   

Abstract

Keywords:  FDA-approved drugs; drug design; pharmacokinetic principles; virtual screening

Mesh：

Substances：

Year:  2020        PMID： 33320017     DOI： 10.1080/17425255.2021.1865309

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN： 1742-5255            Impact factor:   4.481


× No keyword cloud information.
  5 in total

1.  In Silico Study of Cucurbita maxima Compounds as Potential Therapeutics Against Schistosomiasis.

Authors:  Floryn Lynorah Mtemeli; Ryman Shoko; Joice Ndlovu; Grace Mugumbate
Journal:  Bioinform Biol Insights       Date:  2022-05-20

2.  Drug-like Properties and Fraction Lipophilicity Index as a combined metric.

Authors:  Anna Tsantili-Kakoulidou; Vassilis J Demopoulos
Journal:  ADMET DMPK       Date:  2021-10-10

Review 3.  Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.

Authors:  Ioana-Andreea Lungu; Octavia-Laura Moldovan; Victoria Biriș; Aura Rusu
Journal:  Pharmaceutics       Date:  2022-08-22       Impact factor: 6.525

4.  Bioactive Compounds in Garlic (Allium sativum) and Black Garlic as Antigout Agents, Using Computer Simulation.

Authors:  Ayu Rahmania Lestari; Irmanida Batubara; Setyanto Tri Wahyudi; Auliya Ilmiawati; Suminar Setiati Achmadi
Journal:  Life (Basel)       Date:  2022-07-27

5.  Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.

Authors:  Mohammed Baqur S Al-Shuhaib; Hayder O Hashim; Jafar M B Al-Shuhaib
Journal:  Comput Biol Med       Date:  2021-12-17       Impact factor: 6.698
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.